R
Rapid Dose Therapeutics Corp
CNSX:DOSE
Rapid Dose Therapeutics Corp
CNSX:DOSE
Price:
0.14
CAD
Market Closed
Market Cap:
CA$19m
Income Statement
Earnings Waterfall
Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp
Income Statement
Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp
Currency: CAD
| Nov-2019 | Feb-2020 | May-2020 | Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | May-2022 | Aug-2022 | Nov-2022 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Revenue |
0
N/A
|
0
+80%
|
0
+0%
|
(1)
N/A
|
0
N/A
|
1
+294%
|
0
-48%
|
1
+115%
|
1
+39%
|
1
-17%
|
1
-33%
|
1
-23%
|
0
-53%
|
1
+336%
|
1
-19%
|
1
+63%
|
2
+20%
|
2
+30%
|
2
+18%
|
3
+6%
|
3
+6%
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Gross Profit |
0
N/A
|
0
-11%
|
0
+1%
|
(1)
N/A
|
0
N/A
|
1
+415%
|
0
-58%
|
1
+128%
|
1
+35%
|
1
-15%
|
0
-38%
|
0
-28%
|
0
-62%
|
1
+335%
|
0
-13%
|
1
+67%
|
1
+17%
|
1
+23%
|
1
+11%
|
1
+4%
|
1
+3%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(10)
|
(8)
|
(8)
|
(4)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(1)
|
(4)
|
(4)
|
(5)
|
(6)
|
(5)
|
(5)
|
(5)
|
(4)
|
|
| Selling, General & Administrative |
(9)
|
(7)
|
(7)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(1)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(4)
|
(4)
|
|
| Research & Development |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(10)
N/A
|
(8)
+23%
|
(8)
-6%
|
(4)
+44%
|
(2)
+50%
|
(2)
+30%
|
(2)
-50%
|
(3)
-41%
|
(4)
-8%
|
(2)
+42%
|
(3)
-25%
|
(2)
+9%
|
(1)
+63%
|
(3)
-251%
|
(4)
-16%
|
(4)
-24%
|
(5)
-3%
|
(4)
+9%
|
(4)
+11%
|
(3)
+8%
|
(3)
+10%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(10)
N/A
|
(8)
+21%
|
(8)
-6%
|
(5)
+42%
|
(2)
+51%
|
(2)
+25%
|
(2)
+7%
|
(2)
+2%
|
(2)
-17%
|
(2)
-15%
|
(3)
-23%
|
(3)
+8%
|
(1)
+61%
|
(4)
-339%
|
(4)
+0%
|
(5)
-26%
|
(6)
-7%
|
(5)
+6%
|
(5)
+10%
|
(5)
+6%
|
(4)
+5%
|
|
| Net Income | ||||||||||||||||||||||
| Income from Continuing Operations |
(10)
|
(8)
|
(8)
|
(5)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(1)
|
(4)
|
(4)
|
(5)
|
(6)
|
(5)
|
(5)
|
(5)
|
(4)
|
|
| Net Income (Common) |
(10)
N/A
|
(8)
+21%
|
(8)
-6%
|
(5)
+42%
|
(2)
+51%
|
(2)
+25%
|
(2)
+7%
|
(2)
+2%
|
(2)
-17%
|
(2)
-15%
|
(3)
-23%
|
(3)
+8%
|
(1)
+61%
|
(4)
-339%
|
(4)
+0%
|
(5)
-26%
|
(6)
-7%
|
(5)
+6%
|
(5)
+10%
|
(5)
+6%
|
(4)
+5%
|
|
| EPS (Diluted) |
-0.13
N/A
|
-0.1
+23%
|
-0.11
-10%
|
-0.06
+45%
|
-0.03
+50%
|
-0.02
+33%
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.03
-50%
|
-0.02
+33%
|
-0.01
+50%
|
-0.04
-300%
|
-0.04
N/A
|
-0.05
-25%
|
-0.05
N/A
|
-0.04
+20%
|
-0.04
N/A
|
-0.04
N/A
|
-0.04
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
